[artículo] 
inEuropean Neuropsychopharmacology > Año 2015 - Vol. 25 - No. 5 (Mayo) . - pp. 671-681

Título :	The current and potential impact of genetics and genomics on neuropsychopharmacology
Tipo de documento:	texto impreso
Autores:	Paul J. Harrison, Autor
Fecha de publicación:	2021
Artículo en la página:	pp. 671-681
Idioma :	Inglés (eng) Idioma original : Inglés (eng)
Palabras clave:	Antipsicótico, Respuesta farmacológica, Neuroléptico, Farmacogenética, Farmacogenómica, Esquizofrenia, Tolcapona
Resumen:	One justification for the major scientific and financial investments in genetic and genomic studies in medicine is their therapeutic potential, both for revealing novel targets for drugs which treat the disease process, as well as allowing for more effective and safe use of existing medications.
Link:	./index.php?lvl=notice_display&id=26435

[artículo] The current and potential impact of genetics and genomics on neuropsychopharmacology [texto impreso] / Paul J. Harrison, Autor . - 2021 . - pp. 671-681.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in European Neuropsychopharmacology > Año 2015 - Vol. 25 - No. 5 (Mayo) . - pp. 671-681

Palabras clave:	Antipsicótico, Respuesta farmacológica, Neuroléptico, Farmacogenética, Farmacogenómica, Esquizofrenia, Tolcapona
Resumen:	One justification for the major scientific and financial investments in genetic and genomic studies in medicine is their therapeutic potential, both for revealing novel targets for drugs which treat the disease process, as well as allowing for more effective and safe use of existing medications.
Link:	./index.php?lvl=notice_display&id=26435